<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    438257
   </pmid>
   <datecreated>
    <year>
     1979
    </year>
    <month>
     07
    </month>
    <day>
     28
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1979
    </year>
    <month>
     07
    </month>
    <day>
     28
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2010
    </year>
    <month>
     10
    </month>
    <day>
     25
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0021-9355
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       61
      </volume>
      <issue>
       4
      </issue>
      <pubdate>
       <year>
        1979
       </year>
       <month>
        Jun
       </month>
      </pubdate>
     </journalissue>
     <title>
      The Journal of bone and joint surgery. American volume
     </title>
     <isoabbreviation>
      J Bone Joint Surg Am
     </isoabbreviation>
    </journal>
    <articletitle>
     Subcutaneous atrophy following methylprednisolone injection in Osgood-Schlatter epiphysitis.
    </articletitle>
    <pagination>
     <medlinepgn>
      627-8
     </medlinepgn>
    </pagination>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Rostron
      </lastname>
      <forename>
       P K
      </forename>
      <initials>
       PK
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Calver
      </lastname>
      <forename>
       R F
      </forename>
      <initials>
       RF
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     UNITED STATES
    </country>
    <medlineta>
     J Bone Joint Surg Am
    </medlineta>
    <nlmuniqueid>
     0014030
    </nlmuniqueid>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      83-43-2
     </registrynumber>
     <nameofsubstance>
      Methylprednisolone
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adipose Tissue
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Atrophy
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Child
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Injections
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Knee
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Methylprednisolone
     </descriptorname>
     <qualifiername majortopicyn="N">
      administration &amp; dosage
     </qualifiername>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Osteochondritis
     </descriptorname>
     <qualifiername majortopicyn="N">
      complications
     </qualifiername>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Skin Diseases
     </descriptorname>
     <qualifiername majortopicyn="Y">
      chemically induced
     </qualifiername>
    </meshheading>
   </meshheadinglist>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1979
     </year>
     <month>
      6
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1979
     </year>
     <month>
      6
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1979
     </year>
     <month>
      6
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     438257
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

